跳转至内容
Merck

CS0720

柠檬酸合酶检测试剂盒

1 kit sufficient for 100 reactions (using a 1 ml cuvette), 1 kit sufficient for 480 reactions (using 96 multiwell plates)

别名:

柠檬酸合酶活性测试试剂盒

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.28
UNSPSC Code:
12161503
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

usage

 kit sufficient for 100 reactions (using a 1 ml cuvette),  kit sufficient for 480 reactions (using 96 multiwell plates)

shipped in

dry ice

storage temp.

−20°C

Gene Information

human ... CS(1431)

General description

柠檬酸合成检测试剂盒(Citrate Synthase Assay Kit)包含了在全细胞抽提物或分离的线粒体中快速便捷地检测柠檬酸合成酶活性的全部所需试剂(并包含了一份阳性对照酶)。此外,本试剂盒还能够检测线粒体内膜的完整性。

Biochem/physiol Actions

柠檬酸合成酶是三羧酸(TCA)循环的启始酶。该酶能够催化二碳的乙酰辅酶A与四碳的草酰乙酸反应,形成六碳的柠檬酸。该酶是线粒体基质的专属标志物。

Analysis Note

体系中引入的DTNB通过柠檬酸合成反应,由于乙酰辅酶A的去乙酰化,进而生成TNB,酶活即通过TNB的颜色得以检测。最终反应产物TNB的吸收峰位于412 nm。


仅试剂盒组分

产品编号
说明

  • Assay buffer for citrate synthase 5x 25 mL

  • Bicine buffer 10 mL

  • CelLytic M Cell Lysis Reagent 10 mL

  • DTNB [5,5'-Dithiobis-(2-nitrobenzoic acid)] 4 mg

  • Acetyl coenzyme A 25 mg

  • Oxaloacetic acid 1 g

  • Citrate synthase (positive control) .1 mL

pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

10 - Combustible liquids

wgk

WGK 3



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容


Postnatal PPARa Activation and Myostatin Inhibition Exert Distinct yet Complimentary Effects on the Metabolic Profile of Obese Insulin-Resistant Mice
Bernardo,B et al.
PLoS ONE, 5(6) (2010)
Elizabeth A Stoll et al.
The Journal of biological chemistry, 286(44), 38592-38601 (2011-09-09)
Although neurogenesis occurs in discrete areas of the adult mammalian brain, neural progenitor cells (NPCs) produce fewer new neurons with age. To characterize the molecular changes that occur during aging, we performed a proteomic comparison between primary-cultured NPCs from the
Stefan M Gehrig et al.
Experimental physiology, 93(11), 1190-1198 (2008-06-24)
Contraction-mediated injury is a major contributing factor to the pathophysiology of muscular dystrophy and therefore therapies that can attenuate this type of injury have clinical relevance. Systemic administration of insulin-like growth factor-I (IGF-I) has been shown to improve muscle function